# Philippe Hantraye

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/philippe-hantraye/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,513 |
| Field | Genetic Neurodegenerative Diseases |
| h-index | 73 |
| i10-index | 190 |
| Last Known Institution | Université Paris-Sud |
| OpenAlex ID | https://openalex.org/A5051377002 |
| ORCID iD | https://orcid.org/0000-0002-5121-1831 |
| Works | 298 |

## Researcher papers

- [Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease](https://scholariq.org/papers/neurodegeneration-prevented-by-lentiviral-vector-delivery-of-gdnf-in-primate/)
- [Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial](https://scholariq.org/papers/long-term-safety-and-tolerability-of-prosavin-a-lentiviral-vector-based-gene/)
- [Lentiviral Gene Transfer to the Nonhuman Primate Brain](https://scholariq.org/papers/lentiviral-gene-transfer-to-the-nonhuman-primate-brain/)

## Researcher topics

- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

## Researcher university

- [Université Paris-Sud](https://scholariq.org/institutions/universite-paris-sud/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.